CONDITION
MECHANISM
FEATURES
CLUE · TREATMENT
Ethanol → ↑ NADH → ↑ fatty acid synthesis, ↓ β-oxidation; ↓ lipoprotein export
Macrovesicular fat, hepatomegaly; mild enzyme rise
Reversible with abstinence
Acetaldehyde and ROS injure hepatocytes
Ballooned hepatocytes, Mallory-Denk bodies (cytokeratin aggregates), neutrophils; fever, tender hepatomegaly, jaundice
AST:ALT > 2 · steroids if severe
Insulin resistance → fat accumulates → steatohepatitis (NASH) → fibrosis
Obesity, diabetes, dyslipidemia; usually silent; ALT > AST
Leading cause of chronic liver disease · weight loss
Chronic injury → stellate (Ito) cells in the space of Disse become myofibroblasts (TGF-β) → collagen
Diffuse bridging fibrosis + regenerative nodules; shrunken nodular liver
Alcohol → micronodular · viral → macronodular · ↑ HCC risk
Pre-hepatic (portal vein thrombosis), intrahepatic (cirrhosis, schistosomiasis), post-hepatic (Budd-Chiari, right heart failure)
Varices, caput medusae, splenomegaly → thrombocytopenia, ascites
Nonselective β-blocker · TIPS (↑ encephalopathy)
Portal pressure + low albumin + RAAS activation → Na⁺ and water retention
Shifting dullness, fluid wave
SAAG ≥ 1.1 → portal hypertension · spironolactone + furosemide, paracentesis
Spontaneous bacterial peritonitis
Gut bacteria translocate into ascites (E coli, Klebsiella)
Fever, abdominal pain, encephalopathy — or silent
Ascitic PMNs ≥ 250/mm³ · ceftriaxone · prophylaxis
Splanchnic vasodilation → renal vasoconstriction (functional)
Rising creatinine, oliguria, FENa < 1%; normal sediment; no response to fluids
Albumin + vasoconstrictor (terlipressin) · transplant
Intrapulmonary vasodilation (↑ NO) → shunting
Platypnea (dyspnea upright), orthodeoxia, hypoxemia
Bubble echo: delayed left-sided bubbles
↓ hepatic clearance of estrogen; ↑ SHBG
Spider angiomas, palmar erythema, gynecomastia, testicular atrophy
Plus coagulopathy, jaundice, asterixis